Dr. Issa discusses infection prevention and management after stem cell transplant, focusing on how infection risks change throughout the transplant journey. The presentation covers common bacterial, fungal, and viral infections; the impact of immunosuppression and GVHD; vaccination recommendations; and practical strategies to reduce infection risk. Dr. Issa also addresses questions about water safety, COVID-19 vaccination, shingles vaccination, and the development of a CMV vaccine.

Dr. Michael Stephens reviews how graft-versus-host disease (GVHD) can affect the skin, nails, fascia, and hair after an allogeneic stem cell transplant. He covers common symptoms, the importance of early treatment, treatment options, and supportive care such as moisturizing, sun protection, staying active, and reporting new symptoms.

Dr. Ashley Nelson discusses chronic fatigue after stem cell transplant and CAR T-cell therapy, including its causes and how it can affect daily life. She also offers practical strategies for managing fatigue through pacing, exercise, nutrition, sleep, symptom tracking, and professional support.

This presentation explains how CAR T-cell therapy is used to treat multiple myeloma, including how it works, approved treatments, benefits, side effects, and options if myeloma returns. It also highlights newer CAR T approaches being studied, including new targets, faster manufacturing, and earlier use in treatment.

Advanced age has traditionally been seen as a barrier to stem cell transplant and CAR T-cell therapy. This presentation reviews evidence that overall fitness and other factors are important in reducing non-relapse mortality and that otherwise healthy elderly patients can have successful outcomes.

Dr. Luke Mountjoy provides an overview of CAR T-cell therapy for lymphoma, including eligibility, how treatment works, expected benefits, side effects, and recovery. He also discusses infection risks, long-term considerations, and emerging CAR T approaches for lymphoma and other cancers.

Dr. Theresa Callard-Moore discusses how cancer treatment and transplant can affect sexual health, intimacy, and relationships. She covers common physical and emotional challenges and offers practical strategies for communication, rebuilding intimacy, managing discomfort, and getting support from the healthcare team.

This presentation explores how survivors can find meaning and purpose after cancer, transplant, CAR T, and chronic GVHD. Drs. El-Jawahri and Traeger discuss how reflection, personal strengths, values, and meaningful connections can help survivors make sense of their experiences and move forward.

This presentation discusses the incidence and type of new cancers that may occur long-term after a bone marrow/stem cell transplant or CAR T-cell therapy, why they happen, how to detect symptoms, strategies to reduce the risk of new cancers, and long-term survivorship care plans.

Dr. Tara Gregory reviews maintenance therapy for multiple myeloma after stem cell transplant and CAR-T-cell therapy, including treatment options, duration, side effect management, and the growing role of minimal residual disease (MRD) testing. She also discusses how CAR-T and bispecific antibodies are shaping the future of myeloma treatment.